Oral tranexamic acid for acute management of active bleeding from iris microhemangiomatosis: A case report
Purpose: to report a case of active intraocular bleeding caused by iris microhemangiomatosis managed with oral tranexamic acid. Observations: an 80-year-old male was referred to our emergency department for acute intraocular bleeding. Eye exam showed filiform bleeding arising from a cluster of vascu...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-03-01
|
| Series: | American Journal of Ophthalmology Case Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2451993624000100 |
| _version_ | 1827346039179313152 |
|---|---|
| author | Dario Marangoni Antonio Gemito Serena Milan Daniele Tognetto |
| author_facet | Dario Marangoni Antonio Gemito Serena Milan Daniele Tognetto |
| author_sort | Dario Marangoni |
| collection | DOAJ |
| description | Purpose: to report a case of active intraocular bleeding caused by iris microhemangiomatosis managed with oral tranexamic acid. Observations: an 80-year-old male was referred to our emergency department for acute intraocular bleeding. Eye exam showed filiform bleeding arising from a cluster of vascular tufts at the upper pupillary margin, which was consistent with a diagnosis of iris microhemangiomatosis. The bleeding had started 6 hours before and could not be halted by conservative maneuvers such as ocular compression and application of sympathomimetic drops. Oral tranexamic acid 500 mg was administered and led to prompt resolution of the hemorrhage within 60 minutes. The patient was monitored for 3 months and showed no recurrence of the hemorrhage. Conclusion and importance: oral tranexamic acid may represent a viable option to manage active intraocular bleeding from iris microhemangiomatosis, facilitating rapid hemorrhage resolution. |
| first_indexed | 2024-03-07T23:22:25Z |
| format | Article |
| id | doaj.art-f9c097b555b44aab983344741ff2aa45 |
| institution | Directory Open Access Journal |
| issn | 2451-9936 |
| language | English |
| last_indexed | 2024-03-07T23:22:25Z |
| publishDate | 2024-03-01 |
| publisher | Elsevier |
| record_format | Article |
| series | American Journal of Ophthalmology Case Reports |
| spelling | doaj.art-f9c097b555b44aab983344741ff2aa452024-02-21T05:29:23ZengElsevierAmerican Journal of Ophthalmology Case Reports2451-99362024-03-0133102000Oral tranexamic acid for acute management of active bleeding from iris microhemangiomatosis: A case reportDario Marangoni0Antonio Gemito1Serena Milan2Daniele Tognetto3Corresponding author. Eye Clinic, University of Trieste, Ospedale Maggiore, Piazza dell’Ospitale 1, 34129, Trieste, Italy.; Eye Clinic, Department of Medical Surgical Sciences and Health, University of Trieste, 34129, Trieste, ItalyEye Clinic, Department of Medical Surgical Sciences and Health, University of Trieste, 34129, Trieste, ItalyEye Clinic, Department of Medical Surgical Sciences and Health, University of Trieste, 34129, Trieste, ItalyEye Clinic, Department of Medical Surgical Sciences and Health, University of Trieste, 34129, Trieste, ItalyPurpose: to report a case of active intraocular bleeding caused by iris microhemangiomatosis managed with oral tranexamic acid. Observations: an 80-year-old male was referred to our emergency department for acute intraocular bleeding. Eye exam showed filiform bleeding arising from a cluster of vascular tufts at the upper pupillary margin, which was consistent with a diagnosis of iris microhemangiomatosis. The bleeding had started 6 hours before and could not be halted by conservative maneuvers such as ocular compression and application of sympathomimetic drops. Oral tranexamic acid 500 mg was administered and led to prompt resolution of the hemorrhage within 60 minutes. The patient was monitored for 3 months and showed no recurrence of the hemorrhage. Conclusion and importance: oral tranexamic acid may represent a viable option to manage active intraocular bleeding from iris microhemangiomatosis, facilitating rapid hemorrhage resolution.http://www.sciencedirect.com/science/article/pii/S2451993624000100Iris microhemangiomatosisTranexamic acidIntraocular bleeding |
| spellingShingle | Dario Marangoni Antonio Gemito Serena Milan Daniele Tognetto Oral tranexamic acid for acute management of active bleeding from iris microhemangiomatosis: A case report American Journal of Ophthalmology Case Reports Iris microhemangiomatosis Tranexamic acid Intraocular bleeding |
| title | Oral tranexamic acid for acute management of active bleeding from iris microhemangiomatosis: A case report |
| title_full | Oral tranexamic acid for acute management of active bleeding from iris microhemangiomatosis: A case report |
| title_fullStr | Oral tranexamic acid for acute management of active bleeding from iris microhemangiomatosis: A case report |
| title_full_unstemmed | Oral tranexamic acid for acute management of active bleeding from iris microhemangiomatosis: A case report |
| title_short | Oral tranexamic acid for acute management of active bleeding from iris microhemangiomatosis: A case report |
| title_sort | oral tranexamic acid for acute management of active bleeding from iris microhemangiomatosis a case report |
| topic | Iris microhemangiomatosis Tranexamic acid Intraocular bleeding |
| url | http://www.sciencedirect.com/science/article/pii/S2451993624000100 |
| work_keys_str_mv | AT dariomarangoni oraltranexamicacidforacutemanagementofactivebleedingfromirismicrohemangiomatosisacasereport AT antoniogemito oraltranexamicacidforacutemanagementofactivebleedingfromirismicrohemangiomatosisacasereport AT serenamilan oraltranexamicacidforacutemanagementofactivebleedingfromirismicrohemangiomatosisacasereport AT danieletognetto oraltranexamicacidforacutemanagementofactivebleedingfromirismicrohemangiomatosisacasereport |